$7.08
-0.06-0.84%
At Close: -
$7.00
-0.08-1.07%
After Hours: 6:52 PM EDT
15 minutes delayed
Comments
Loading...
Aurinia Pharmaceuticals (AUPH) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAurinia Pharmaceuticals (NASDAQ:AUPH) Stock Quotes, Forecast and News Summary
Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
| Open | $7.17 |
| Close | $7.08 |
| Volume / Avg. | 929.37K / 1.41M |
| Day Range | $6.99 - $7.34 |
| 52 Wk Range | 4.71 - 10.05 |
| Market Cap | $1.00B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 60 |
| Short Interest | 6.13% |
| Days to Cover | 5.33 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffer...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aurinia Pharmaceuticals (AUPH) stock?
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) through any online brokerage.
Who are Aurinia Pharmaceuticals (AUPH) competitors?
There are no as such competitors for Aurinia Pharmaceuticals.
What is the forecast, or price target, for Aurinia Pharmaceuticals (AUPH) stock?
Aurinia Pharmaceuticals has a consensus price target of $10.75.
What is the current price for Aurinia Pharmaceuticals (AUPH)?
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $7.0044 last updated September 18, 2024 at 6:52 PM EDT.
Does Aurinia Pharmaceuticals (AUPH) pay a dividend?
There are no upcoming dividends for Aurinia Pharmaceuticals.
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Aurinia Pharmaceuticals (AUPH) going to split?
There is no upcoming split for Aurinia Pharmaceuticals.
What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.